Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boston Children's Hospital
With
Massachusetts General Hospital
Massachusetts Institute of Technology
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Madrid-MIT M+Visión Consortium
Age
18–45
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
1. The pregnant mother with twin gestation with diagnosis of selective IUGR based upon obstetrical US findings as following:
* Proven monochorionicity / dichorionicity
* Discordance in estimated fetal weight (EFW). Growth restriction (\<10 percentile of norm) in one or both fetus(es) AND/OR growth discordance (\> or = 20%) between twin fetuses.
2. The pregnant mother with singleton gestation with diagnosis of IUGR based upon obstetrical US findings as following:
* Proven singleton gestation
* Growth restriction of fetus (\<10 percentile of norm)
* Doppler measurements that indicates placental insufficiency: umbilical artery, middle cerebral artery, uterine artery; or oligohydramnios.
3. Gestational age: Bigger than 18 weeks.
4. Pregnant mother is between age 18 to 45, clinically stable and can safely tolerate fetal MRI study.
You may not be if
Fetuses/infants with the following features will be excluded.
1. Fetus/infant with chromosomal anomalies or known genetic disorders.
2. Fetus/infant with other major congenital malformation.
3. Presence of any condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient, quality or completeness of the data.
Pregnant mothers with the following features will be excluded.
1. Mothers with contraindication to MRI (with pacemaker, metal in body, oversize).